<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pearl: A Foundation Model for Placing Every Atom in the Right Location - Health AI Hub</title>
    <meta name="description" content="Pearl is a novel foundation model designed to accurately predict the three-dimensional structures of protein-ligand complexes, addressing key limitations in com">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Pearl: A Foundation Model for Placing Every Atom in the Right Location</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2510.24670v1" target="_blank">2510.24670v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-10-28
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Genesis Research Team, Alejandro Dobles, Nina Jovic, Kenneth Leidal, Pranav Murugan, David C. Williams, Drausin Wulsin, Nate Gruver, Christina X. Ji, Korrawat Pruegsanusak, Gianluca Scarpellini, Ansh Sharma, Wojciech Swiderski, Andrea Bootsma, Richard Strong Bowen, Charlotte Chen, Jamin Chen, Marc Andr√© D√§mgen, Roy Tal Dew, Benjamin DiFrancesco, J. D. Fishman, Alla Ivanova, Zach Kagin, David Li-Bland, Zuli Liu, Igor Morozov, Jeffrey Ouyang-Zhang, Frank C. Pickard IV, Kushal S. Shah, Ben Shor, Gabriel Monteiro da Silva, Maxx Tessmer, Carl Tilbury, Cyr Vetcher, Daniel Zeng, Maruan Al-Shedivat, Aleksandra Faust, Evan N. Feinberg, Michael V. LeVine, Matteus Pan
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, q-bio.QM
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2510.24670v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2510.24670v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">Pearl is a novel foundation model designed to accurately predict the three-dimensional structures of protein-ligand complexes, addressing key limitations in computational drug discovery. It achieves state-of-the-art performance by leveraging large-scale synthetic data, an SO(3)-equivariant diffusion architecture, and controllable inference mechanisms. The model significantly outperforms existing methods, including AlphaFold 3, on major benchmarks, promising to accelerate therapeutic design.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Precisely predicting protein-ligand interactions is crucial for rational drug design, enabling the faster and more accurate identification and optimization of potential drug candidates. This technology directly impacts the efficiency and success rates of developing new therapeutics.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>Pearl is an AI foundation model designed to accelerate computational drug discovery by accurately predicting the 3D structures of protein-ligand complexes. This allows for more efficient identification, design, and optimization of potential drug candidates, directly impacting the development of new treatments and therapies.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the fundamental challenge of accurately predicting 3D protein-ligand complex structures, which is a significant bottleneck in computational drug discovery.</li>
                    
                    <li>Overcomes data scarcity through innovative training recipes that incorporate large-scale synthetic data.</li>
                    
                    <li>Utilizes an SO(3)-equivariant diffusion module in its architecture to inherently respect 3D rotational symmetries, enhancing generalization and sample efficiency.</li>
                    
                    <li>Features controllable inference, including a generalized multi-chain templating system supporting both protein and non-polymeric components, and dual unconditional/conditional modes.</li>
                    
                    <li>Establishes new state-of-the-art performance, surpassing AlphaFold 3 and other open-source baselines by 14.5% on Runs N' Poses and 14.2% on PoseBusters for generating accurate (RMSD < 2 √Ö) and physically valid poses.</li>
                    
                    <li>Delivers a 3.6-fold improvement in pocket-conditional cofolding at a more rigorous RMSD < 1 √Ö threshold on a proprietary set of challenging, real-world drug targets.</li>
                    
                    <li>Demonstrates a direct correlation between model performance and the size of the synthetic dataset used in training, indicating scalability and potential for further improvement.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>Pearl employs a deep learning framework featuring an SO(3)-equivariant diffusion module for inherent 3D symmetry respect. Its training leverages large-scale synthetic data to mitigate experimental data limitations. The inference system is highly controllable, supporting generalized multi-chain templating for diverse molecular components (polymeric and non-polymeric) and offering both unconditional and conditional prediction modes.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>Pearl achieved state-of-the-art performance in protein-ligand cofolding, outperforming AlphaFold 3 by 14.5% on Runs N' Poses and 14.2% on PoseBusters for accurate (RMSD < 2 √Ö) and physically valid poses. In a pocket-conditional cofolding regime, it delivered a 3.6x improvement at the more stringent RMSD < 1 √Ö threshold on challenging, real-world drug targets. Model performance was directly correlated with the size of the synthetic dataset utilized during training.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>By significantly enhancing the accuracy and reliability of protein-ligand structure prediction, Pearl can streamline the early stages of drug discovery. This acceleration enables researchers to identify and optimize drug candidates more efficiently, potentially leading to the faster development of novel and more effective therapeutics across various disease areas, ultimately reducing R&D costs and time-to-market for new medicines.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations or caveats of the Pearl model itself. It primarily highlights the challenges in the field that Pearl aims to address.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The observed direct correlation between model performance and the size of the synthetic dataset suggests that further improvements in prediction accuracy can be achieved by expanding the scale and diversity of synthetic data used for training.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Medicinal Chemistry</span>
                    
                    <span class="tag">Drug Development</span>
                    
                    <span class="tag">Structural Biology</span>
                    
                    <span class="tag">Bioinformatics</span>
                    
                    <span class="tag">Therapeutic Design</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">protein-ligand cofolding</span>
                    
                    <span class="tag tag-keyword">foundation model</span>
                    
                    <span class="tag tag-keyword">drug discovery</span>
                    
                    <span class="tag tag-keyword">computational chemistry</span>
                    
                    <span class="tag tag-keyword">deep learning</span>
                    
                    <span class="tag tag-keyword">SO(3)-equivariance</span>
                    
                    <span class="tag tag-keyword">protein structure prediction</span>
                    
                    <span class="tag tag-keyword">synthetic data</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Accurately predicting the three-dimensional structures of protein-ligand
complexes remains a fundamental challenge in computational drug discovery that
limits the pace and success of therapeutic design. Deep learning methods have
recently shown strong potential as structural prediction tools, achieving
promising accuracy across diverse biomolecular systems. However, their
performance and utility are constrained by scarce experimental data,
inefficient architectures, physically invalid poses, and the limited ability to
exploit auxiliary information available at inference. To address these issues,
we introduce Pearl (Placing Every Atom in the Right Location), a foundation
model for protein-ligand cofolding at scale. Pearl addresses these challenges
with three key innovations: (1) training recipes that include large-scale
synthetic data to overcome data scarcity; (2) architectures that incorporate an
SO(3)-equivariant diffusion module to inherently respect 3D rotational
symmetries, improving generalization and sample efficiency, and (3)
controllable inference, including a generalized multi-chain templating system
supporting both protein and non-polymeric components as well as dual
unconditional/conditional modes. Pearl establishes a new state-of-the-art
performance in protein-ligand cofolding. On the key metric of generating
accurate (RMSD < 2 \r{A}) and physically valid poses, Pearl surpasses AlphaFold
3 and other open source baselines on the public Runs N' Poses and PoseBusters
benchmarks, delivering 14.5% and 14.2% improvements, respectively, over the
next best model. In the pocket-conditional cofolding regime, Pearl delivers
$3.6\times$ improvement on a proprietary set of challenging, real-world drug
targets at the more rigorous RMSD < 1 \r{A} threshold. Finally, we demonstrate
that model performance correlates directly with synthetic dataset size used in
training.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>